We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSCD icon
3126
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$24.3M
$346K ﹤0.01%
4,386
-89
-2% -$7.06K
FCF icon
3127
First Commonwealth Financial
FCF
$2.19B
$345K ﹤0.01%
24,721
-1,078
-4% -$15.2K
HEEM icon
3128
iShares Currency Hedged MSCI Emerging Markets
HEEM
$293M
$345K ﹤0.01%
15,027
-2,795
-16% -$65.9K
KGC icon
3129
Kinross Gold
KGC
$31.9B
$344K ﹤0.01%
84,223
-92,629
-52% -$366K
NURE icon
3130
Nuveen Short-Term REIT ETF
NURE
$35.3M
$344K ﹤0.01%
12,093
+2,419
+25% +$71.4K
RIG icon
3131
Transocean
RIG
$6.39B
$343K ﹤0.01%
75,245
+14,435
+24% +$55.7K
FSR
3132
DELISTED
Fisker Inc.
FSR
$343K ﹤0.01%
47,139
-6,912
-13% -$51.4K
BTAI icon
3133
BioXcel Therapeutics
BTAI
$34.9M
$342K ﹤0.01%
996
+247
+33% +$59.7K
KTF
3134
DWS Municipal Income Trust
KTF
$352M
$342K ﹤0.01%
39,719
+16,103
+68% +$136K
SKE
3135
Skeena Resources
SKE
$4.07B
$342K ﹤0.01%
64,268
+51,237
+393% +$260K
CHCO icon
3136
City Holding Co
CHCO
$2.08B
$341K ﹤0.01%
3,667
-509
-12% -$49K
QVAL icon
3137
Alpha Architect US Quantitative Value ETF
QVAL
$614M
$340K ﹤0.01%
10,571
BX icon
3138
CALL
Blackstone
BX
$112B
$340K ﹤0.01%
64,400
+14,400
+29% +$1.24M
TXNM
3139
TXNM Energy Inc
TXNM
$5.91B
$339K ﹤0.01%
+6,941
New +$330K
M icon
3140
Macy's
M
$6.27B
$337K ﹤0.01%
16,338
+4,797
+42% +$98.2K
OR icon
3141
OR Royalties Inc
OR
$6.15B
$337K ﹤0.01%
27,949
-3,372
-11% -$39.1K
SD icon
3142
SandRidge Energy
SD
$516M
$337K ﹤0.01%
+19,781
New +$370K
IBTX
3143
DELISTED
Independent Bank Group, Inc.
IBTX
$337K ﹤0.01%
5,606
+59
+1% +$3.75K
TLRY icon
3144
Tilray
TLRY
$640M
$335K ﹤0.01%
12,470
+3,104
+33% +$109K
CRNC icon
3145
Cerence
CRNC
$389M
$335K ﹤0.01%
18,100
-7,084
-28% -$121K
MBSD icon
3146
FlexShares Disciplined Duration MBS Index Fund
MBSD
$89M
$334K ﹤0.01%
16,377
+1,076
+7% +$21.8K
SCPL
3147
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$332K ﹤0.01%
20,665
-1,453
-7% -$21.1K
ZTR
3148
Virtus Total Return Fund
ZTR
$338M
$332K ﹤0.01%
50,657
+10,238
+25% +$66.7K
BBD icon
3149
Banco Bradesco
BBD
$34.3B
$331K ﹤0.01%
115,059
-932,778
-89% -$3.02M
MRK icon
3150
CALL
Merck
MRK
$334B
$331K ﹤0.01%
54,500
+19,800
+57% +$2.02M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.